Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Jul;76(1):E13-E14.
doi: 10.1002/hep.32389. Epub 2022 Mar 6.

Letter to the editor: Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter study

Xuemei Tao  1 , Youfei Zhao  1 , Lin Chen  1 , Minghui Zeng  1 , Yuqiang Mi  1   2   3 , Liang Xu  1   2   3
Affiliations
Multicenter Study

Letter to the editor: Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter study

Xuemei Tao et al. Hepatology. 2022 Jul.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Wang CY, Deng Y, Li P, Zheng S, Chen G, Zhou G, et al. Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: a large multicenter study. Hepatology. 2021 Dec 16. https://doi.org/10.1002/hep.32283. [Epub ahead of print]
    1. Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M, et al. Incidence and etiology of drug-induced liver injury in Mainland China. Gastroenterology. 2019;156:2230-41.e11.
    1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: drug-induced liver injury. J Hepatol. 2019;70:1222-61.
    1. Fontana RJ, Hayashi PH, Barnhart H, Kleiner DE, Reddy KR, Chalasani N, et al. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury. Am J Gastroenterol. 2015;110:1450-9.
    1. Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4:389-98.

MeSH terms